| 2024-10 |
A phase 1 study of biweekly nab-paclitaxel/oxaliplatin/S-1/LV for advanced upper gastrointestinal cancers: TCOG T1216 study |
Oncologist. 2024 Oct 3;29(10):e1396-e1405. |
 |
| 2020-05 |
A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data |
Gastric Cancer. 2020 May;23(3):510-519. |
|
| 2016-08-24 |
A phase I clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment |
Journal of Biomedical Science. 2016 Aug 24;23:Article number 64. |
|
| 2017-05 |
A phase I dose escalation study of SCBO1A, a micro tubular inhibitor with vascular disrupting activity, in patients with advanced solid tumors refractory to standard therapy |
Journal of Clinical Oncology. 2017 May;35(Suppl. 15):Meeting Abstract 2531. |
|
| 2014-05 |
A phase I dose escalation study of weekly BI 836845, a fully human, affinity-optineized, insulin -like growth factor (IGF) ligand neutralizing antibody, in patients with advanced solid cancers |
Journal of Clinical Oncology. 2014 May;32(15, Suppl.):2617. |
|
| 2016-11-21 |
A phase I dose-escalation study of PEP02 (irinotecan liposome injection) in combination with 5-fluorouracil and leucovorin in advanced solid tumors |
BMC Cancer. 2016 Nov 21;16:Article number 907. |
|
| 2021-03 |
A phase II clinical trial on the combination therapy of PHY906 plus capecitabine in hepatocellular carcinoma |
Oncologist. 2021 Mar;26(3):e367-e373. |
|
| 2022-04 |
A phase II randomised trial of induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced pancreatic cancer: the Taiwan Cooperative Oncology Group T2212 study |
British Journal of Cancer. 2022 Apr;126(7):1018-1026. |
|
| 2015-12 |
A phase II study of sequential capecitabine plus oxaliplatin (XELOX) followed by docetaxel plus capecitabine (TX) in patients with unresectable gastric adenocarcinoma-TCOG 3211 clinical trial |
Journal of Gastroenterology and Hepatology. 2015 Dec;30(Suppl. S4):99. |
|
| 2015-05 |
A phase II study of sequential capecitabine plus oxaliplatin (XELOX) followed by docetaxel plus capecitabine (TX) in patients with unresectable gastric adenocarcinoma: The TCOG T3211 trial |
Journal of Clinical Oncology. 2015 May;33(15, Suppl.):4024. |
|
| 2016-01 |
A phase II study of sequential capecitabine plus oxaliplatin followed by docetaxel plus capecitabine in patients with unresectable gastric adenocarcinoma: The TCOG 3211 clinical trial |
Medicine. 2016 Jan;95(3):Article number e2565. |
|
| 2017-02 |
A phase II trial of modified gemcitabine plus S-1 combination as the first-line treatment in patients with advanced biliary tract cancer |
Journal of Clinical Oncology. 2017 Feb;35(4, Suppl.):417. |
|
| 2021-09 |
A phase II trial of nivolumab and gemcitabine and S-1 as the first-line treatment in patients with advanced biliary tract cancer |
Annals of Oncology. 2021 Sep;32(Suppl. 5):S377. |
|
| 2017-07 |
A phase II trial of regorafenib in patients with metastatic and/or a unresectable gastrointestinal stromal tumor harboring secondary mutations of exon 17 |
Oncotarget. 2017 Jul;8(27):44121-44130. |
|
| 2019-02 |
A phase II trial of TAS-120 in patients with intrahepatic cholangiocarcinoma harboring FGFR2 gene rearrangements |
Journal of Clinical Oncology. 2019 Feb;37(4, Suppl.):Abstract number TPS468. |
|
| 2020-02 |
A phase III study of nivolumab (Nivo) in previously treated advanced gastric or gastric esophageal junction (G/GEJ) cancer (ATTRACTION-2): Three-year update data |
Journal of Clinical Oncology. 2020 Feb;38(4):Meeting Abstract 383. |
|
| 2019-08-12 |
A piezoceramic sensor for detection of focused ultrasound-induced cavitation |
IEEE Sensors Journal. 2019 Aug 12;19(22):10379-10385. |
|
| 2024-07-01 |
A pilot study of 16-week intensive outpatient treatment for gay and bisexual men with methamphetamine use disorder in Taiwan |
Drug and Alcohol Dependence. 2024 Jul 01;260(Suppl.):Meeting Abstract 110867. |
|
| 2020-10-21 |
A polypeptide of tumor-associated antigen L6 with intrinsic adjuvant activity enhances antitumor immunity |
Vaccines. 2020 Oct 21;8(4):Article number 620. |
|
| 2022-10-10 |
A polysaccharide isolated from the herb bletilla striata combined with methylcellulose to form a hydrogel via self-assembly as a wound dressing |
International Journal of Molecular Sciences. 2022 Oct 10;23(19):Article number 1201. |
|
| 2022-02 |
A portable controllable compressive stress device to monitor human breast cancer cell protrusions at single-cell resolution |
Frontiers in Bioengineering and Biotechnology. 2022 Feb;10:Article number 852318. |
|
| 2019-04 |
A post-hoc study of D-Amino acid Oxidase in blood as an indicator of Post-stroke Dementia |
Frontiers in Neurology. 2019 Apr;10:Article number 402. |
|
| 2017-01 |
A potent, selective, and orally bioavailable HCV NS5A inhibitor for treatment of Hepatitis C Virus: (S)-1-((R)-2-(Cyclopropanecarboxamido)-2-phenylacetyl)-N-(4-phenylthiazo l-2-yl)pyrrolidine-2-carboxamide |
Journal of Medicinal Chemistry. 2017 Jan;60(1):228-247. |
|
| 2015-03-06 |
A potential interaction between COMT and MTHFR genetic variants in Han Chinese patients with bipolar II disorder |
Scientific Reports. 2015 Mar 6;5:Article number 8813. |
|
| 2022-02-01 |
A prediction model for tumor recurrence in stage II–III colorectal cancer patients: From a machine learning model to genomic profiling |
Biomedicines. 2022 Feb 1;10(2):Article number 340. |
|
